Onpharma Launches First Solana-Based STO for US Medical Device Business

A groundbreaking Security Token Offering (STO) has been launched on the Solana blockchain for Onpharma Company, a US-based medical device business. This is believed to be the first STO of its kind in the world.

The STO was made possible through the collaboration between First Block, a digital securities and tokenization infrastructure company, Onpharma Company, and Crito Capital LLP, a UK-based investment banking and advisory firm. The offering allows investors to purchase tokens representing ownership rights in Onpharma's common stock, rather than traditional shares.

The STO is structured as a Regulation S offshore issuance to non-US investors, combining the legal certainty of an exempt securities offering with the operational efficiency of Solana infrastructure.

The investment case for Onpharma is strong. The company has developed a medical device technology for dentistry that addresses a significant market opportunity. Its product, the Onset EZ Pen, provides improved patient experience and has already gained traction in the market.